ALB and neoplasm: In our previous works, the preparationof docetaxel (DTX)-loadedHSA NPs to design a tumor-targeted drug delivery system based on theHSA conjugation strategy has been reported.17 Since DTX is a very toxic anticancer agent with low water solubility,to overcome these side effects and improve the antitumor efficacyof DTX, this time it was encapsulated in HSA NPs produced by a desolvationmethod and achieved an alternative system for DTX delivery.